Latest Content

Nubeqa Improves 3-Year Survival in Nonmetastatic Prostate Cancer

January 26th 2021, 2:00pm

By Darlene Dobkowski, MA

Article

At three years, overall survival in men with nonmetastatic, castration-resistant prostate cancer treated with Nubeqa was 83% compared with 77% in those who received placebo.

Recent Cancer Diagnosis Associated With Increased Risk of COVID-19, Especially in Black Patients

January 25th 2021, 10:00pm

By Colleen Moretti

Article

People recently diagnosed with cancer may be at an increased risk of contracting COVID-19 and experiencing worse outcomes than those who have never had a cancer diagnosis. The association was heightened in Black patients.

National Organization Recommends COVID-19 Vaccine for Patients With Cancer

January 25th 2021, 7:00pm

By Brielle Benyon

Article

The National Comprehensive Cancer Network (NCCN) recommends that patients receiving active cancer treatment get the COVID-19 vaccine.

How To Live In The Present As Cancer Survivors

January 25th 2021, 5:00pm

By Jane Biehl Ph.D.

Article

A simple quote reminds a cancer survivor of what is important for every one of us to remember.

Opdivo Plus Yervoy Improves Survival for Patients with Rare Form of Eye Cancer

January 25th 2021, 4:00pm

By Colleen Moretti

Article

Combination treatment with Opdivo and Yervoy may have better overall survival rates for patients with metastatic uveal melanoma.

Why It’s ‘Never Too Soon’ to Consider Clinical Trials as a Treatment Option

January 25th 2021, 2:00pm

By Jessica Skarzynski

Video

Living With Pancreatic Cancer: a Patient and Provider Perspective

January 24th 2021, 3:00pm

By Kristie L. Kahl

Video

On behalf of the National Pancreas Foundation, CURE spoke with Dr. Michael Goggin, from Johns Hopkins Medicine, and Tom Birsic, an executive board member since the organization’s inception, about living with pancreatic cancer.

How Image Visualization Complemented My Cancer Treatment

January 23rd 2021, 8:00pm

By Viney Kirpal

Article

How the act of image visualization and mediation gave this cancer survivor a helpful complement to her cancer treatment.

7 Recent Cancer-Related Quality of Life Updates Patients May Have Missed

January 23rd 2021, 3:00pm

By Ryan McDonald

Article

CURE® compiled a roundup of several recent news and updates involving quality of life improvements that patients with cancer may have missed.

5 Recent COVID-19 News and Updates That Patients With Cancer May Have Missed

January 22nd 2021, 10:00pm

By Ryan McDonald

Article

CURE® compiled a roundup of five recent pieces of COVID-19 news and updates that patients with cancer may have missed.

FDA Approves Cabometyx-Opdivo For Metastatic RCC Treatment

January 22nd 2021, 7:48pm

By Conor Killmurray

Article

After a fast-track designation, the Food and Drug Administration approved the combination of Cabometyx and Opdivo in the firstline setting for patients with advanced or metastatic renal cell carcinoma.

Novel Therapy Granted Priority Review By FDA for Treatment of Anal Cancer Subset

January 22nd 2021, 7:00pm

By Ryan McDonald

Article

The priority review will focus on retifanlimab for the treatment of certain adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal who did not tolerate platinum-based chemotherapy. Currently, according to Incyte, there are no approved treatments for this patient population.

COVID-19 'Retired' Me, But Now I Can Reach For My Life Goals

January 22nd 2021, 5:00pm

By Marissa Holzer

Article

With a terminal illness of metastatic breast cancer, I qualify for Social Security Disability as the COVID-19 pandemic has retired me, but that isn't stopping me from achieving my life goals.

Friday Frontline: Marine Veteran Has Walked More Than 8,000 Miles to Raise Cancer Awareness and Funds for Strangers Treatments, Researchers Use Cancer Cells From Osteosarcoma Donor for Treatment Breakthrough, And More

January 22nd 2021, 4:00pm

By Conor Killmurray

Article

From a Marine veteran walking 8,500 miles over the last 24 years to raise cancer awareness and funds for treatment to researchers using cancer cells from a deceased osteosarcoma donor to help advance treatment, here’s what’s happening in the cancer landscape this week.

Oral Contraceptives May Reduce Endometrial, Ovarian Cancer Risk Decades After Stopping Use

January 22nd 2021, 2:00pm

By Colleen Moretti

Article

Women who reported using oral contraceptives had a decreased risk of endometrial and ovarian cancer, compared to those who never used the hormone medications. The data also indicated the association extended up to three decades after patients stopped using the contraceptives.